Indian students in US TPCI
Higher education: A pathway to economic development

India needs to focus on strategies to improve student-teacher ratio, enhance academic research in new age technologies and provide livelihood opportunities to students exploring the country in order t...

The next decade could see many Indian innovative companies emerge

C S Murali, Chairman, Entrepreneurship Cell, Society for Innovation and Development, IISc Bangalore, discusses how the institute’s STEM incubation cell handholds startups towards successful commerci...

A $100 bn opportunity for engineering R&D

India has an expected business potential of US$ 100 billion in the engineering R&D sector in the coming years, which could create additional employment for 1-1.25 million people. In order to capitalis...

Kapil Malhotra
Featured Interview
PLI scheme could boost prospects for fluoropolymers

Kapil Malhotra, Senior Vice President - Marketing, with Gujarat Fluorochemicals Ltd, is confident of market revival post-COVID for fluoropolymers across end-use segments including automotive, healthca...

Indian Defence
Defence Acquisition Procedure 2020: Will it smooth the path for self reliance?

Defence Acquisition Procedure 2020 tries to simplify purchases with a focus on domestic capability. However, India needs a simultaneous push towards R&D investments and building a robust export market...

Tanaz Buhariwalla Ireland
Ireland is an attractive destination for growth-stage Indian startups

Tanaz Buhariwalla, Director, IDA Ireland, discusses Ireland’s key advantages as a business destination for Indian companies, including a business-friendly ecosystem, competitive costs, support for i...

Amaresh Chakrabarti, IISC, manufacturing
Why the glass is half-full for Indian manufacturing!

Amaresh Chakrabarti, Senior Professor and Chairman, Centre for Product Design & Manufacturing, IISc, explains how the institute is creating innovator entrepreneurs and also enabling effective interfac...

Ship-building & naval systems should be key focus areas for the defence sector

The import embargo on 101 items in defence indicates confidence in the government that India has sufficient defence-industrial capacity in these items. Since the Indian Navy is the most indigenized in...

Indian pharma post-COVID: On the innovation trail?

Post-COVID-19, India needs to strengthen its pharma R&D ecosystem to tap into emerging drug development opportunities and changing paradigms in the new drug development framework.....

Sanjay Singh Partner – Deal Advisory, Head of Lifesciences, KPMG in India
Patent expiries present a US$ 212 bn opportunity for Indian pharma

Sanjay Singh, Partner – Deal Advisory, Head of Lifesciences, KPMG in India, identifies new generics opportunities, established manufacturing ecosystem, growing penetration of health insurance and ta...

Load More

Subscribe To Newsletter

Get to know of latest happening in TPCI & in the world of trade and commerce